Trials / Sponsors / Peter Hosein, MD
Peter Hosein, MD
Academic / Other · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) o Neuroendocrine Carcinoma, Neuroendocrine Tumors | Phase 1 | 2025-05-19 |
| Completed | Combined MEK, STAT3 and PD-1 Inhibition in Metastatic Pancreatic Ductal Adenocarcinoma Pancreatic Ductal Adenocarcinoma | Phase 1 | 2023-01-19 |